StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)

Close on Nov 18, 2026Market cap $106.09MP/E –Yield –

Lexaria Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lexaria Bioscience's price to sales ratio was 445.9× on Oct 30, 2026, against 415.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 30, 2026445.9×+189.5
2025Dec 31, 2025256.4×−139.4
2023Sep 29, 2023395.8×−83.2
2021Dec 31, 2021479.0×–

More Lexaria Bioscience figures

See a number that looks wrong?